Small Molecule Modulators of K eap1‐ N rf2‐ ARE Pathway as Potential Preventive and Therapeutic Agents
Open accessAbstract
Kelch-like ECH-associated protein 1 (Keap1)-nuclear factor erythroid 2-related factor 2 (Nrf2)-antioxidant response elements (ARE) pathway represents one of the most important cellular defense mechanisms against oxidative stress and xenobiotic damage. Activation of Nrf2 signaling induces the transcriptional regulation of ARE-dependent expression of various detoxifying and antioxidant defense enzymes and proteins. Keap1-Nrf2-ARE signaling has become an attractive target for the prevention and treatment of oxidative stress-related diseases and conditions including cancer, neurodegenerative, cardiovascular, metabolic, and inflammatory diseases. Over the last few decades, numerous Nrf2 inducers have been developed and some of them are currently undergoing clinical trials. Recently, overactivation of Nrf2 has been implicated in cancer progression as well as in drug resistance to cancer chemotherapy. Thus, Nrf2 inhibitors could potentially be used to improve the effectiveness of cancer therapy. Herein, we review the signaling mechanism of Keap1-Nrf2-ARE pathway, its disease relevance, and currently known classes of small molecule modulators. We also discuss several aspects of Keap1-Nrf2 interaction, Nrf2-based peptide inhibitor design, and the screening assays currently used for the discovery of direct inhibitors of Keap1-Nrf2 interaction.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Mitochondria are responsible for the production of the majority of ROS within a cell.
“Mitochondria are responsible for the production of the majority of ROS within a cell, and these potentially harmful radicals are modulated by the expression of endogenous antioxidants involving the nuclear factor erythroid 2-related factor 2 (Nrf2)- kelch-like ECH-associated protein 1 (Keap1) pathway [Magesh et al., 2012] or via external anti-oxidants in the diet [Birch-Machin and Oyewole 2015;”
From Oxidative stress and ageing (2016) · cites this paper as Magesh et al., 2012
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
2 retracted
Nuclear Import and Export Signals in Control of Nrf2
Jain, A. K., Bloom, D. A., & Jaiswal, A. K. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m502083200 · Cited by 194 · see citing works
RetractedPing, Z., Liu, W., Kang, Z., Cai, J., Wang, Q., Cheng, N., Wang, S., Wang, S., Zhang, J. H., & Sun, X. (2010) · Brain Research · doi:10.1016/j.brainres.2010.04.036 · Cited by 153 · see citing works
RetractedOxidants, oxidative stress and the biology of ageing
Finkel, T., & Holbrook, N. J. (2000) · Nature · doi:10.1038/35041687 · Cited by 9,413 · see citing works
Metals, Toxicity and Oxidative Stress
Valko, M., Morris, H., & Cronin, M. (2005) · Current Medicinal Chemistry · doi:10.2174/0929867053764635 · Cited by 5,018 · see citing works
Itoh, K., Chiba, T., Takahashi, S., Ishii, T., Igarashi, K., Katoh, Y., Oyake, T., Hayashi, N., Satoh, K., Hatayama, I., et al. (1997) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1997.6943 · Cited by 3,999 · see citing works
Neurodegenerative diseases and oxidative stress
Barnham, K. J., Masters, C. L., & Bush, A. I. (2004) · Nature Reviews Drug Discovery · doi:10.1038/nrd1330 · Cited by 3,683 · see citing works
Itoh, K., Wakabayashi, N., Katoh, Y., Ishii, T., Igarashi, K., Engel, J. D., & Yamamoto, M. (1999) · Genes & Development · doi:10.1101/gad.13.1.76 · Cited by 3,634 · see citing works
Cell Survival Responses to Environmental Stresses Via the Keap1-Nrf2-ARE Pathway
Kensler, T. W., Wakabayashi, N., & Biswal, S. (2007) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.46.120604.141046 · Cited by 3,630 · see citing works
The chemical diversity and distribution of glucosinolates and isothiocyanates among plants
Fahey, J. W., Zalcmann, A. T., & Talalay, P. (2001) · Phytochemistry · doi:10.1016/s0031-9422(00)00316-2 · Cited by 2,968 · see citing works
BIOLOGY AND BIOCHEMISTRY OF GLUCOSINOLATES
Halkier, B. A., & Gershenzon, J. (2006) · Annual Review of Plant Biology · doi:10.1146/annurev.arplant.57.032905.105228 · Cited by 2,279 · see citing works
Kobayashi, A., Kang, M.-I., Okawa, H., Ohtsuji, M., Zenke, Y., Chiba, T., Igarashi, K., & Yamamoto, M. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.16.7130-7139.2004 · Cited by 2,224 · see citing works
Curcumin as “Curecumin”: From kitchen to clinic
Goel, A., Kunnumakkara, A. B., & Aggarwal, B. B. (2007) · Biochemical Pharmacology · doi:10.1016/j.bcp.2007.08.016 · Cited by 2,220 · see citing works
RAO, A., & RAO, L. (2007) · Pharmacological Research · doi:10.1016/j.phrs.2007.01.012 · Cited by 2,024 · see citing works
Dinkova-Kostova, A. T., Holtzclaw, W. D., Cole, R. N., Itoh, K., Wakabayashi, N., Katoh, Y., Yamamoto, M., & Talalay, P. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.172398899 · Cited by 1,947 · see citing works
Antioxidant and radical scavenging properties of curcumin
Ak, T. P., & Gülçın, İ. (2008) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2008.05.003 · Cited by 1,942 · see citing works
Curcumin: From ancient medicine to current clinical trials
Hatcher, H., Planalp, R. P., Cho, J., Torti, F. M., & Torti, S. V. (2008) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-008-7452-4 · Cited by 1,847 · see citing works
Nrf2:INrf2 (Keap1) signaling in oxidative stress
Kaspar, J. W., Niture, S. K., & Jaiswal, A. K. (2009) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2009.07.035 · Cited by 1,646 · see citing works
Free radicals and antioxidants in human health: current status and future prospects.
Devasagayam, T. P. A., Tilak, J. C., Boloor, K. K., Sane, K. S., Ghaskadbi, S., & Lele, R. D. (2004) · PubMed · Cited by 1,563 · see citing works
Zhang, D. D., & Hannink, M. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.22.8137-8151.2003 · Cited by 1,480 · see citing works
Molecular mechanisms of the Keap1-Nrf2 pathway in stress response and cancer evolution
Taguchi, K., Motohashi, H., & Yamamoto, M. (2011) · Genes to Cells · doi:10.1111/j.1365-2443.2010.01473.x · Cited by 1,478 · see citing works
Rushmore, T. H., Morton, M. R., & Pickett, C. B. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)99004-6 · Cited by 1,464 · see citing works
Keap1 Is a Redox-Regulated Substrate Adaptor Protein for a Cul3-Dependent Ubiquitin Ligase Complex
Zhang, D. D., Lo, S., Cross, J. V., Templeton, D. J., & Hannink, M. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.24.10941-10953.2004 · Cited by 1,262 · see citing works
Mechanistic Studies of the Nrf2-Keap1 Signaling Pathway
Zhang, D. D. (2006) · Drug Metabolism Reviews · doi:10.1080/03602530600971974 · Cited by 1,091 · see citing works
Molecular Mechanisms Activating the Nrf2-Keap1 Pathway of Antioxidant Gene Regulation
Kobayashi, M., & Yamamoto, M. P. (2005) · Antioxidants and Redox Signaling · doi:10.1089/ars.2005.7.385 · Cited by 1,075 · see citing works
Oxidative stress, exercise, and antioxidant supplementation
Urso, M. L., & Clarkson, P. M. (2003) · Toxicology · doi:10.1016/s0300-483x(03)00151-3 · Cited by 1,067 · see citing works
Balogun, E. A., Hoque, M., Gong, P., Killeen, E., Green, C. J., Foresti, R., Alam, J., & Motterlini, R. (2003) · Biochemical Journal · doi:10.1042/bj20021619 · Cited by 1,038 · see citing works
The cytoprotective role of the Keap1–Nrf2 pathway
Baird, L., & Dinkova‐Kostova, A. T. (2011) · Archives of Toxicology · doi:10.1007/s00204-011-0674-5 · Cited by 1,029 · see citing works
Antioxidant Properties of Ferulic Acid and Its Related Compounds
Kikuzaki, H., Hisamoto, M., Hirose, K., Akiyama, K., & Taniguchi, H. (2002) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf011348w · Cited by 1,016 · see citing works
Chronic inflammation and oxidative stress in human carcinogenesis
Federico, A., Morgillo, F., Tuccillo, C., Ciardiello, F., & Loguercio, C. (2007) · International Journal of Cancer · doi:10.1002/ijc.23192 · Cited by 1,001 · see citing works
Wakabayashi, N., Dinkova-Kostova, A. T., Holtzclaw, W. D., Kang, M.-I., Kobayashi, A., Yamamoto, M., Kensler, T. W., & Talalay, P. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0307301101 · Cited by 986 · see citing works
Alpha-lipoic acid as a dietary supplement: Molecular mechanisms and therapeutic potential
Shay, K. P., Moreau, R. F., Smith, E. J., Smith, A. R., & Hagen, T. M. (2009) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2009.07.026 · Cited by 976 · see citing works
Kobayashi, A., Kang, M.-I., Watai, Y., Tong, K. I., Shibata, T., Uchida, K., & Yamamoto, M. P. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.26.1.221-229.2006 · Cited by 933 · see citing works
Chronic Inflammation and Oxidative Stress as a Major Cause of Age- Related Diseases and Cancer
Khansari, N., Shakiba, Y., & Mahmoudi, M. (2009) · Recent Patents on Inflammation & Allergy Drug Discovery · doi:10.2174/187221309787158371 · Cited by 922 · see citing works
Bardoxolone Methyl and Kidney Function in CKD with Type 2 Diabetes
Pergola, P. E., Raskin, P., Toto, R. D., Meyer, C. J., Huff, J. W., Grossman, E. B., Krauth, M., Ruiz, S., Audhya, P., Christ-Schmidt, H., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1105351 · Cited by 890 · see citing works
NRF2 and KEAP1 mutations: permanent activation of an adaptive response in cancer
Hayes, J. D., & McMahon, M. J. (2009) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2008.12.008 · Cited by 870 · see citing works
Oxidative Stress and Neurotoxicity
Sayre, L. M., Perry, G. L., & Smith, M. A. (2007) · Chemical Research in Toxicology · doi:10.1021/tx700210j · Cited by 868 · see citing works
Nrf2 enhances resistance of cancer cells to chemotherapeutic drugs, the dark side of Nrf2
Wang, X.-J., Sun, Z., Villeneuve, N. F., Zhang, S., Zhao, F., Li, Y., Chen, W., Yi, X., Zheng, W., Wondrak, G. T., et al. (2008) · Carcinogenesis · doi:10.1093/carcin/bgn095 · Cited by 839 · see citing works
Molecular mechanisms of Nrf2‐mediated antioxidant response
Li, W., & Kong, A. T. (2008) · Molecular Carcinogenesis · doi:10.1002/mc.20465 · Cited by 786 · see citing works
Valenzano, D. R., Tozzini, E. T., Genade, T., Cattaneo, A., Domenici, L., & Cellerino, A. (2006) · Current Biology · doi:10.1016/j.cub.2005.12.038 · Cited by 786 · see citing works
Stress-activated cap’n’collar transcription factors in aging and human disease
Sykiotis, G. P., & Bohmann, D. (2010) · Science Signaling · doi:10.1126/scisignal.3112re3 · Cited by 776 · see citing works
Expression of Nrf2 in Neurodegenerative Diseases
Ramsey, C. P., Glass, C. A., Montgomery, M. B., Lindl, K. A., Ritson, G. P., Chia, L. A., Hamilton, R. L., Chu, C. T., & Jordan-Sciutto, K. L. (2007) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/nen.0b013e31802d6da9 · Cited by 760 · see citing works
Surh, Y., Kundu, J. K., & Na, H. (2008) · Planta Medica · doi:10.1055/s-0028-1088302 · Cited by 759 · see citing works
Tong, K. I., Katoh, Y., Kusunoki, H., Itoh, K., Tanaka, T., & Yamamoto, M. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.26.8.2887-2900.2006 · Cited by 759 · see citing works
Oxidative stress and apoptosis: Impact on cancer therapy
Ozben, T. (2007) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.20874 · Cited by 751 · see citing works
Benson, A. M., Hunkeler, M. J., & Talalay, P. (1980) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.77.9.5216 · Cited by 750 · see citing works
An Important Role of Nrf2-ARE Pathway in the Cellular Defense Mechanism
Lee, J., & Johnson, J. A. (2004) · BMB Reports · doi:10.5483/bmbrep.2004.37.2.139 · Cited by 746 · see citing works
Structural basis for defects of Keap1 activity provoked by its point mutations in lung cancer
Padmanabhan, B., Tong, K. I., Ohta, T., Nakamura, Y., Scharlock, M., Ohtsuji, M., Kang, M.-I., Kobayashi, A., Yokoyama, S., & Yamamoto, M. (2006) · Molecular Cell · doi:10.1016/j.molcel.2006.01.013 · Cited by 735 · see citing works
Multitargeted cancer prevention by quercetin
Murakami, A., Ashida, H., & Terao, J. (2008) · Cancer Letters · doi:10.1016/j.canlet.2008.03.046 · Cited by 729 · see citing works
Shibata, T., Ohta, T., Tong, K. I., Kokubu, A., Odogawa, R., Tsuta, K., Asamura, H., Yamamoto, M., & Hirohashi, S. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0806268105 · Cited by 728 · see citing works
Functional antioxidant responsive elements
Wasserman, W. W., & Fahl, W. E. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.10.5361 · Cited by 705 · see citing works
Martı́n, D., Rojo, A. I., Salinas, M., Díaz, R. G., Gallardo, G., Alam, J., de Galarreta, C. M. R., & Cuadrado, A. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m309660200 · Cited by 698 · see citing works
Brusatol enhances the efficacy of chemotherapy by inhibiting the Nrf2-mediated defense mechanism
Ren, D., Villeneuve, N. F., Jiang, T., Wu, T., Lau, A., Toppin, H. A., & Zhang, D. D. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1014275108 · Cited by 673 · see citing works
Kwak, M.-K., Wakabayashi, N., Itoh, K., Motohashi, H., Yamamoto, M. P., & Kensler, T. W. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m211898200 · Cited by 661 · see citing works
LAU, A., VILLENEUVE, N., Sun, Z., Wong, P. K., & Zhang, D. (2008) · Pharmacological Research · doi:10.1016/j.phrs.2008.09.003 · Cited by 645 · see citing works
Kobayashi, M., Li, L., Iwamoto, N., Nakajima‐Takagi, Y., Kaneko, H., Nakayama, Y., Eguchi, M., Wada, Y., Kumagai, Y., & Yamamoto, M. P. (2008) · Molecular and Cellular Biology · doi:10.1128/mcb.01080-08 · Cited by 641 · see citing works
Loss of Keap1 Function Activates Nrf2 and Provides Advantages for Lung Cancer Cell Growth
Ohta, T., Iijima, K., Miyamoto, M., Nakahara, I., Tanaka, H., Ohtsuji, M., Suzuki, T., Kobayashi, A., Yokota, J., Sakiyama, T., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-5003 · Cited by 630 · see citing works
Chalcones: An Update on Cytotoxic and Chemoprotective Properties
Go, M., Wu, X., & Liu, X. (2005) · Current Medicinal Chemistry · doi:10.2174/0929867053363153 · Cited by 619 · see citing works
Structure of the Keap1:Nrf2 interface provides mechanistic insight into Nrf2 signaling
Lo, S., Li, X., Henzl, M. T., Beamer, L. J., & Hannink, M. (2006) · The EMBO Journal · doi:10.1038/sj.emboj.7601243 · Cited by 604 · see citing works
Dimmock, J. R., Elias, D., Beazely, M. A., & Kandepu, N. (1999) · Current Medicinal Chemistry · doi:10.2174/0929867306666220401182509 · Cited by 599 · see citing works
When NRF2 Talks, Who's Listening?
Wakabayashi, N., Slocum, S. L., Skoko, J. J., Shin, S., & Kensler, T. W. (2010) · Antioxidants & Redox Signaling · doi:10.1089/ars.2010.3216 · Cited by 595 · see citing works
Dinkova‐Kostova, A. T., Massiah, M. A., Bozak, R. E., Hicks, R. J., & Talalay, P. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.051632198 · Cited by 594 · see citing works
Chen, P.-C., Vargas, M. R., Pani, A. K., Smeyne, R. J., Johnson, D. A., Kan, Y. W., & Johnson, J. A. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0813361106 · Cited by 579 · see citing works
Basic Principles and Emerging Concepts in the Redox Control of Transcription Factors
Brigelius-Flohé, R., & Flohé, L. (2011) · Antioxidants and Redox Signaling · doi:10.1089/ars.2010.3534 · Cited by 577 · see citing works
Dinkova‐Kostova, A. T., Liby, K. T., Stephenson, K. K., Holtzclaw, W. D., Gao, X., Suh, N., Williams, C. R., Risingsong, R., Honda, T., Gribble, G. W., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0500815102 · Cited by 575 · see citing works
Ungvari, Z. I., Bagi, Z. A., Fehér, A., Recchia, F. A., Sonntag, W. E., Pearson, K. J., de Cabo, R., & Csiszár, A. (2010) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00260.2010 · Cited by 571 · see citing works
Mechanisms of cadmium carcinogenesis☆
Joseph, P. (2009) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2009.01.011 · Cited by 539 · see citing works
Kang, M.-I., Kobayashi, A., Wakabayashi, N., Kim, S.-G., & Yamamoto, M. P. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0308347100 · Cited by 536 · see citing works
Direct and indirect antioxidant properties of inducers of cytoprotective proteins
Dinkova‐Kostova, A. T., & Talalay, P. (2008) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.200700195 · Cited by 535 · see citing works
Nrf2, a multi‐organ protector?
Lee, J., Li, J., Johnson, D. A., Stein, T. D., Kraft, A. D., Calkins, M. J., Jakel, R. J., & Johnson, J. A. (2005) · The FASEB Journal · doi:10.1096/fj.04-2591hyp · Cited by 532 · see citing works
Nrf2-Deficient Mice Have an Increased Susceptibility to Dextran Sulfate Sodium–Induced Colitis
Khor, T. O., Huang, M., Kwon, K. H., Chan, J. Y., Reddy, B. S., & Kong, A. T. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-3562 · Cited by 530 · see citing works
Physiological Significance of Reactive Cysteine Residues of Keap1 in Determining Nrf2 Activity
Yamamoto, T., Suzuki, T., Kobayashi, A., Wakabayashi, J., Maher, J. M., Motohashi, H., & Yamamoto, M. P. (2008) · Molecular and Cellular Biology · doi:10.1128/mcb.01704-07 · Cited by 515 · see citing works
Nioi, P., McMahon, M. J., Itoh, K., Yamamoto, M. P., & Hayes, J. D. (2003) · Biochemical Journal · doi:10.1042/bj20030754 · Cited by 508 · see citing works
Xu, L., Yue, W., Reboul, J., Vaglio, P., Shin, T.-H., Vidal, M., Elledge, S. J., & Harper, J. W. (2003) · Nature · doi:10.1038/nature01985 · Cited by 497 · see citing works
McMahon, M. J., Thomas, N., Itoh, K., Yamamoto, M. P., & Hayes, J. D. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m601119200 · Cited by 489 · see citing works
Nrf2: friend or foe for chemoprevention?
Kensler, T. W., & Wakabayashi, N. (2009) · Carcinogenesis · doi:10.1093/carcin/bgp231 · Cited by 487 · see citing works
Action of Nrf2 and Keap1 in ARE-mediated NQO1 expression by quercetin
Tanigawa, S., Fujii, M., & Hou, D.-X. (2007) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2007.02.017 · Cited by 483 · see citing works
The Nrf2 System as a Potential Target for the Development of Indirect Antioxidants
Jung, K.-A., & Kwak, M. (2010) · Molecules · doi:10.3390/molecules15107266 · Cited by 476 · see citing works
Two-site substrate recognition model for the Keap1-Nrf2 system: A hinge and latch mechanism
Tong, K. I., Kobayashi, A., Katsuoka, F., & Yamamoto, M. (2006) · Biological Chemistry · doi:10.1515/bc.2006.164 · Cited by 473 · see citing works
The pathways and molecular mechanisms regulating Nrf2 activation in response to chemical stress
Nguyen, T., Yang, C. S., & Pickett, C. B. (2004) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2004.04.033 · Cited by 463 · see citing works
Eggler, A. L., Liu, G., Pezzuto, J. M., van Breemen, R. B., & Mesecar, A. D. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0502402102 · Cited by 459 · see citing works
Tong, K. I., Padmanabhan, B., Kobayashi, A., Shang, C., Hirotsu, Y., Yokoyama, S., & Yamamoto, M. P. (2007) · Molecular and Cellular Biology · doi:10.1128/mcb.00753-07 · Cited by 447 · see citing works
Kode, A., Rajendrasozhan, S., Caito, S., Yang, S.-R., Megson, I. L., & Rahman, I. (2008) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00361.2007 · Cited by 447 · see citing works
McMahon, M. J., Lamont, D. J., Beattie, K. A., & Hayes, J. D. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1007387107 · Cited by 445 · see citing works
Yang, C., Zhang, X., Fan, H., & Liu, Y. (2009) · Brain Research · doi:10.1016/j.brainres.2009.05.009 · Cited by 444 · see citing works
The Nrf2/ARE Pathway as a Potential Therapeutic Target in Neurodegenerative Disease
Calkins, M. J., Johnson, D. A., Townsend, J. A., Vargas, M. R., Dowell, J. A., Williamson, T. P., Kraft, A. D., Lee, J., Li, J., & Johnson, J. A. (2008) · Antioxidants and Redox Signaling · doi:10.1089/ars.2008.2242 · Cited by 440 · see citing works
The Protective Role of Nrf2 in Streptozotocin-Induced Diabetic Nephropathy
Jiang, T., Huang, Z., Lin, Y., Zhang, Z., Fang, D., & Zhang, D. D. (2010) · Diabetes · doi:10.2337/db09-1342 · Cited by 440 · see citing works
de Vries, H. E., Witte, M. E., Hondius, D., Rozemüller, A. J. M., Drukarch, B., Hoozemans, J. J. M., & van Horssen, J. (2008) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2008.09.001 · Cited by 432 · see citing works
Molecular actions of Ebselen—an antiinflammatory antioxidant
SCHEWE, T. (1995) · General Pharmacology The Vascular System · doi:10.1016/0306-3623(95)00003-j · Cited by 431 · see citing works
Oxidative Stress and Antioxidants in Exercise
Leeuwenburgh, C., & Heinecke, J. W. (2001) · Current Medicinal Chemistry · doi:10.2174/0929867013372896 · Cited by 430 · see citing works
Villeneuve, N. F., Lau, A., & Zhang, D. D. (2010) · Antioxidants and Redox Signaling · doi:10.1089/ars.2010.3211 · Cited by 423 · see citing works
Chemoprotection against cancer by induction of Phase 2 enzymes
Talalay, P. (2000) · BioFactors · doi:10.1002/biof.5520120102 · Cited by 421 · see citing works
The integrated antioxidant system
Jacob, R. A. (1995) · Nutrition Research · doi:10.1016/0271-5317(95)00041-g · Cited by 420 · see citing works
Dhakshinamoorthy, S., Jain, A. K., Bloom, D. A., & Jaiswal, A. K. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m500166200 · Cited by 414 · see citing works
McMahon, M. J., Thomas, N., Itoh, K., Yamamoto, M. P., & Hayes, J. D. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m403061200 · Cited by 406 · see citing works
Hong, F., Freeman, M. L., & Liebler, D. C. (2005) · Chemical Research in Toxicology · doi:10.1021/tx0502138 · Cited by 404 · see citing works
Nrf2 signaling and cell survival
Niture, S. K., Kaspar, J. W., Shen, J., & Jaiswal, A. K. (2009) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2009.06.009 · Cited by 397 · see citing works
Satoh, T., Kosaka, K., Itoh, K., Kobayashi, A., Yamamoto, M. P., Shimojo, Y., Kitajima, C., Cui, J., Kamins, J., Okamoto, S., et al. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.05039.x · Cited by 396 · see citing works
Chen, X., & KUNSCH, C. A. (2004) · Current Pharmaceutical Design · doi:10.2174/1381612043452901 · Cited by 387 · see citing works
The Carboxy-Terminal Neh3 Domain of Nrf2 Is Required for Transcriptional Activation
Nioi, P., Nguyen, T., Sherratt, P. J., & Pickett, C. B. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.24.10895-10906.2005 · Cited by 383 · see citing works
Activation of NRF2 by Nitrosative Agents and H2O2 Involves KEAP1 Disulfide Formation
Fourquet, S., Guérois, R., Biard, D. S. F., & Tolédano, M. B. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.051714 · Cited by 378 · see citing works
FREE RADICALS, ANTIOXIDANTS, DISEASES AND PHYTOMEDICINES: CURRENT STATUS AND FUTURE PROSPECT
Sen, S., Chakraborty, R., Sridhar, C., Reddy, Y. S., & De, B. (2010) · Cited by 378 · see citing works
Arsenic toxicity, mutagenesis, and carcinogenesis – a health risk assessment and management approach
Tchounwou, P. B., Centeno, J. A., & Patlolla, A. K. (2003) · Molecular and Cellular Biochemistry · doi:10.1023/b:mcbi.0000007260.32981.b9 · Cited by 375 · see citing works
Michaluart, P., Masferrer, J. L., Carothers, A. M., Subbaramaiah, K., Zweifel, B. S., Koboldt, C. M., MESTRE, J. R., Grünberger, D., Sacks, P. G., Tanabe, T., et al. (1999) · PubMed · Cited by 374 · see citing works
Nrf2: A Potential Molecular Target for Cancer Chemoprevention by Natural Compounds
Jeong, W., Jun, M., & Kong, A. T. (2006) · Antioxidants and Redox Signaling · doi:10.1089/ars.2006.8.99 · Cited by 371 · see citing works
The Keap1 BTB/POZ dimerization function is required to sequester Nrf2 in cytoplasm
Zipper, L. M., & Mulcahy, R. T. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m206530200 · Cited by 366 · see citing works
Thiol-Based Redox Switches and Gene Regulation
Antelmann, H., & Helmann, J. D. (2010) · Antioxidants and Redox Signaling · doi:10.1089/ars.2010.3400 · Cited by 366 · see citing works
Molecular Targets of Dietary Phenethyl Isothiocyanate and Sulforaphane for Cancer Chemoprevention
Cheung, K. L., & Kong, A. T. (2009) · The AAPS Journal · doi:10.1208/s12248-009-9162-8 · Cited by 365 · see citing works
Redox Regulation by Keap1 and Nrf2 Controls Intestinal Stem Cell Proliferation in Drosophila
Hochmuth, C. E., Biteau, B., Bohmann, D., & Jasper, H. (2011) · Cell stem cell · doi:10.1016/j.stem.2010.12.006 · Cited by 364 · see citing works
Identification of the interactive interface and phylogenic conservation of the Nrf2‐Keap1 system
Kobayashi, M., Itoh, K., Suzuki, T., Osanai, H., Nishikawa, K., Katoh, Y., Takagi, Y., & Yamamoto, M. P. (2002) · Genes to Cells · doi:10.1046/j.1365-2443.2002.00561.x · Cited by 340 · see citing works
Marzec, J. M., Christie, J. D., Reddy, S. P., Jedlicka, A., Vuong, H., Lanken, P. N., Aplenc, R., Yamamoto, T., Yamamoto, M. P., Cho, H., et al. (2007) · The FASEB Journal · doi:10.1096/fj.06-7759com · Cited by 340 · see citing works
Sun, Z., Zhang, S., Chan, J. Y., & Zhang, D. D. (2007) · Molecular and Cellular Biology · doi:10.1128/mcb.00630-07 · Cited by 332 · see citing works
Shapiro, T. A., Fahey, J. W., Dinkova‐Kostova, A. T., Holtzclaw, W. D., Stephenson, K. K., Wade, K. L., Ye, L., & Talalay, P. (2006) · Nutrition and Cancer · doi:10.1207/s15327914nc5501_7 · Cited by 330 · see citing works
Vascular NAD(P)H oxidase activation in diabetes: a double-edged sword in redox signalling
Gao, L., & Mann, G. E. (2009) · Cardiovascular Research · doi:10.1093/cvr/cvp031 · Cited by 330 · see citing works
Jaźwa, A., Rojo, A. I., Innamorato, N. G., Hesse, M., Fernández‐Ruíz, J., & Cuadrado, A. (2011) · Antioxidants and Redox Signaling · doi:10.1089/ars.2010.3731 · Cited by 329 · see citing works
Tang, X., Wang, H., Fan, L., Wu, X., Xin, A., Ren, H.-Y., & Wang, X. J. (2011) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2011.03.008 · Cited by 327 · see citing works
Preclinical and clinical evaluation of sulforaphane for chemoprevention in the breast
Cornblatt, B. S., Ye, L., Dinkova‐Kostova, A. T., Erb, M., Fahey, J. W., Singh, N., Chen, M.-S. A., Stierer, T. L., Garrett-Mayer, E. S., Argani, P., et al. (2007) · Carcinogenesis · doi:10.1093/carcin/bgm049 · Cited by 323 · see citing works
Specific Patterns of Electrophile Adduction Trigger Keap1 Ubiquitination and Nrf2 Activation
Hong, F., Sekhar, K. R., Freeman, M. L., & Liebler, D. C. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m503346200 · Cited by 316 · see citing works
Sporn, M. B., Liby, K. T., Yore, M. M., Fu, L., Lopchuk, J. M., & Gribble, G. W. (2011) · Journal of Natural Products · doi:10.1021/np100826q · Cited by 312 · see citing works
Modification of Keap1 Cysteine Residues by Sulforaphane
Hu, C., Eggler, A. L., Mesecar, A. D., & van Breemen, R. B. (2011) · Chemical Research in Toxicology · doi:10.1021/tx100389r · Cited by 312 · see citing works
Multiple molecular targets in cancer chemoprevention by curcumin
Thangapazham, R. L., Sharma, A. K., & Maheshwari, R. K. (2006) · The AAPS Journal · doi:10.1208/aapsj080352 · Cited by 310 · see citing works
Wang, X. J., Hayes, J. D., Henderson, C. J., & Wolf, C. R. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0709483104 · Cited by 310 · see citing works
Targeting NRF2 signaling for cancer chemoprevention
Kwak, M.-K., & Kensler, T. W. (2009) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2009.08.028 · Cited by 306 · see citing works
Freigang, S., Ampenberger, F., Spohn, G., Heer, S., Shamshiev, A. T., Kisielow, J., Hersberger, M., Yamamoto, M., Bachmann, M. F., & Kopf, M. (2011) · European Journal of Immunology · doi:10.1002/eji.201041316 · Cited by 300 · see citing works
Zhang, D. D., Lo, S., Sun, Z., Habib, G. M., Lieberman, M. W., & Hannink, M. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m501279200 · Cited by 299 · see citing works
MacLeod, A. K., McMahon, M. J., Plummer, S. M., Higgins, L. G., Penning, T. M., Igarashi, K., & Hayes, J. D. (2009) · Carcinogenesis · doi:10.1093/carcin/bgp176 · Cited by 297 · see citing works
Suzuki, M., Betsuyaku, T., Ito, Y., Nagai, K., Nasuhara, Y., Kaga, K., Kondo, S., & Nishimura, M. (2008) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2007-0424oc · Cited by 286 · see citing works
Nagaraj, S., Youn, J., Weber, H., Iclozan, C., Lu, L. D., Cotter, M. J., Meyer, C. J., Becerra, C. R., Fishman, M., Antonia, S. J., et al. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-3272 · Cited by 286 · see citing works
Emerging Role of Nrf2 in Protecting Against Hepatic and Gastrointestinal Disease
Aleksunes, L. M., & Manautou, J. E. (2007) · Toxicologic Pathology · doi:10.1080/01926230701311344 · Cited by 285 · see citing works
Katsuoka, F., Motohashi, H., Ishii, T., Aburatani, H., Engel, J. D., & Yamamoto, M. P. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.18.8044-8051.2005 · Cited by 283 · see citing works
Role of oxidative stress in rheumatoid arthritis: insights from the Nrf2-knockout mice
Wruck, C. J., Fragoulis, A., Gurzynski, A., Brandenburg, L., Kan, Y. W., Chan, K., Hassenpflug, J., Freitag‐Wolf, S., Varoga, D. J., Lippross, S., et al. (2010) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2010.132720 · Cited by 283 · see citing works
Ageing, oxidative stress and cancer: paradigms in parallax
Benz, C. C., & Yau, C. S. F. (2008) · Nature reviews. Cancer · doi:10.1038/nrc2522 · Cited by 279 · see citing works
Enhancing Expression of Nrf2-Driven Genes Protects the Blood–Brain Barrier after Brain Injury
Zhao, J., Moore, A. N., Redell, J. B., & Dash, P. K. (2007) · Journal of Neuroscience · doi:10.1523/jneurosci.1683-07.2007 · Cited by 274 · see citing works
Calabrese, V., Cornelius, C., Mancuso, C., Pennisi, G., Calafato, S., Bellia, F., Bates, T. E., Stella, A. M. G., Schapira, T., Dinkova‐Kostova, A. T., et al. (2008) · Neurochemical Research · doi:10.1007/s11064-008-9775-9 · Cited by 267 · see citing works
On the mechanisms of induction of cancer-protective enzymes: a unifying proposal.
Prochaska, H. J., Long, M. J., & Talalay, P. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.23.8232 · Cited by 260 · see citing works
Phenolic antioxidants from herbs and spices
Nakatani, N. (2000) · BioFactors · doi:10.1002/biof.5520130123 · Cited by 254 · see citing works
Kweon, M., Adhami, V. M., Lee, J., & Mukhtar, H. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m604748200 · Cited by 250 · see citing works
Nrf2 is critical in defense against high glucose-induced oxidative damage in cardiomyocytes
He, X., Kan, H. J., Cai, L., & Ma, Q. (2008) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2008.10.007 · Cited by 249 · see citing works
Dinkova‐Kostova, A. T., & Talalay, P. (1999) · Carcinogenesis · doi:10.1093/carcin/20.5.911 · Cited by 249 · see citing works
Crystal Structure of the Kelch Domain of Human Keap1
Li, X., Zhang, D. D., Hannink, M., & Beamer, L. J. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m410073200 · Cited by 249 · see citing works
Nrf2, a Guardian of Healthspan and Gatekeeper of Species Longevity
Lewis, K. N., Mele, J., Hayes, J. D., & Buffenstein, R. (2010) · Integrative and Comparative Biology · doi:10.1093/icb/icq034 · Cited by 247 · see citing works
Nrf2 protects against airway disorders
Cho, H., & Kleeberger, S. R. (2009) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2009.07.024 · Cited by 237 · see citing works
A Review of Natural and Synthetic Antioxidants Important for Health and Longevity
Wójcik, M., Burzyńska-Pędziwiatr, I., & Woźniak, L. A. (2010) · Current Medicinal Chemistry · doi:10.2174/092986710792231950 · Cited by 235 · see citing works
Eggler, A. L., Gay, K. A., & Mesecar, A. D. (2008) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.200700249 · Cited by 234 · see citing works
Activation of the Nrf2–ARE signaling pathway: a promising strategy in cancer prevention
Giudice, A., & Montella, M. (2006) · BioEssays · doi:10.1002/bies.20359 · Cited by 232 · see citing works
Effect of Bardoxolone Methyl on Kidney Function in Patients with T2D and Stage 3b–4 CKD
Pérgola, P. E., Krauth, M., Huff, J. W., Ferguson, D. A., Ruiz, S., Meyer, C. J., & Warnock, D. G. (2011) · American Journal of Nephrology · doi:10.1159/000327599 · Cited by 232 · see citing works
The rise of antioxidant signaling—The evolution and hormetic actions of Nrf2
Maher, J. M., & Yamamoto, M. P. (2010) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2010.01.011 · Cited by 231 · see citing works
Mechanism of the Nrf2/Keap1/ARE signaling system
Tkachev, V., Брониславовна, М. Е., & Зенков, Н. К. (2011) · Biochemistry (Moscow) · doi:10.1134/s0006297911040031 · Cited by 228 · see citing works
Transcription Factor Nrf2 Protects the Brain From Damage Produced by Intracerebral Hemorrhage
Zhao, X., Sun, G., Zhang, J., Strong, R., Dash, P. K., Kan, Y. W., Grotta, J. C., & Aronowski, J. A. (2007) · Stroke · doi:10.1161/strokeaha.107.486506 · Cited by 227 · see citing works
Regulation of Notch1 Signaling by Nrf2: Implications for Tissue Regeneration
Wakabayashi, N., Shin, S., Slocum, S. L., Agoston, E. S., Wakabayashi, J., Kwak, M.-K., Misra, V., Biswal, S. S., Yamamoto, M. P., & Kensler, T. W. (2010) · Science Signaling · doi:10.1126/scisignal.2000762 · Cited by 224 · see citing works
NRF2 targeting: a promising therapeutic strategy in chronic obstructive pulmonary disease
Boutten, A., Goven, D., Artaud-Macari, É., Boczkowski, J., & Bonay, M. (2011) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2011.02.006 · Cited by 223 · see citing works
Green Tea: Nature's Defense against Malignancies
Butt, M. S., & Sultan, M. T. (2009) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408390802145310 · Cited by 219 · see citing works
Nrf2: control of sensitivity to carcinogens
Slocum, S. L., & Kensler, T. W. (2011) · Archives of Toxicology · doi:10.1007/s00204-011-0675-4 · Cited by 219 · see citing works
A systems biology perspective on Nrf2-mediated antioxidant response
Zhang, Q., Pi, J., Woods, C. G., & Andersen, M. E. (2009) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2009.08.018 · Cited by 217 · see citing works
The role of the antioxidant and longevity-promoting Nrf2 pathway in metabolic regulation
Sykiotis, G. P., Habeos, I. G., Samuelson, A. V., & Bohmann, D. (2010) · Current Opinion in Clinical Nutrition & Metabolic Care · doi:10.1097/mco.0b013e32834136f2 · Cited by 214 · see citing works
Antithrombotic and anticancer effects of garlic-derived sulfur compounds: A review
Ariga, T., & Seki, T. (2006) · BioFactors · doi:10.1002/biof.5520260201 · Cited by 214 · see citing works
Age-Accelerated Atherosclerosis Correlates With Failure to Upregulate Antioxidant Genes
Collins, A. R., Lyon, C. J., Xia, X., Liu, J. Z., Tangirala, R. K., Yin, F., Boyadjian, R., Bikineyeva, A. T., Praticò, D., Harrison, D. G., et al. (2009) · Circulation Research · doi:10.1161/circresaha.108.188771 · Cited by 214 · see citing works
Small molecule modulators of antioxidant response pathway
Hur, W., & Gray, N. S. (2010) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2010.12.009 · Cited by 213 · see citing works
Egner, P. A., Chen, J., Wang, J. B., Wu, Y., Sun, Y., Lu, J. H., Zhu, J., Zhang, Y. H., Chen, Y. S., Friesen, M. D., et al. (2011) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-10-0296 · Cited by 213 · see citing works
Molecular cross-talk between the NRF2/KEAP1 signaling pathway, autophagy, and apoptosis
Stępkowski, T. M., & Kruszewski, M. K. (2011) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2011.01.033 · Cited by 212 · see citing works
Rachakonda, G., Xiong, Y., Sekhar, K. R., Stamer, S. L., Liebler, D. C., & Freeman, M. L. (2008) · Chemical Research in Toxicology · doi:10.1021/tx700302s · Cited by 210 · see citing works
Electrophilic nitro-fatty acids activate NRF2 by a KEAP1 cysteine 151-independent mechanism
Kansanen, E., Bonacci, G., Schopfer, F. J., Kuosmanen, S. M., Tong, K. I., Leinonen, H., Woodcock, S. R., Yamamoto, M., Carlberg, C., Ylä-Herttuala, S., et al. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.190710 · Cited by 208 · see citing works
Muiswinkel, F. L. V., & Kuiperij, H. B. (2005) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/1568007054038238 · Cited by 207 · see citing works
Benson, A. M., Cha, Y. N., Bueding, E., Heine, H. S., & Talalay, P. (1979) · PubMed · Cited by 199 · see citing works
Nrf2 as a target for cancer chemoprevention
Yu, X. Y., & Kensler, T. W. (2005) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/j.mrfmmm.2005.04.017 · Cited by 199 · see citing works
Li, J., Lee, J., & Johnson, J. A. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m109380200 · Cited by 193 · see citing works
McNally, S. J., Harrison, E. M., Ross, J. A., Garden, O. J., & Wigmore, S. J. (2007) · International Journal of Molecular Medicine · doi:10.3892/ijmm.19.1.165 · Cited by 192 · see citing works
Wu, C., Sheen, L., Chen, H.-W., Tsai, S.-J., & Lii, C. (2001) · Food and Chemical Toxicology · doi:10.1016/s0278-6915(00)00171-x · Cited by 192 · see citing works
Sites of alkylation of human Keap1 by natural chemoprevention agents
Luo, Y., Eggler, A. L., Liu, D., Liu, G., Mesecar, A. D., & van Breemen, R. B. (2007) · Journal of the American Society for Mass Spectrometry · doi:10.1016/j.jasms.2007.09.015 · Cited by 191 · see citing works
The Keap1–Nrf2 system as an in vivo sensor for electrophiles
Uruno, A., & Motohashi, H. (2011) · Nitric Oxide · doi:10.1016/j.niox.2011.02.007 · Cited by 187 · see citing works
Curcumin Activates Defensive Genes and Protects Neurons Against Oxidative Stress
Scapagnini, G., Colombrita, C., Amadio, M., D’Agata, V., Arcelli, E., Sapienza, M. A., Quattrone, A., & Calabrese, V. (2006) · Antioxidants and Redox Signaling · doi:10.1089/ars.2006.8.395 · Cited by 185 · see citing works
Garg, R., Gupta, S., & Maru, G. B. (2008) · Carcinogenesis · doi:10.1093/carcin/bgn064 · Cited by 185 · see citing works
Cheng, X., Siow, R. C. M., & Mann, G. E. (2010) · Antioxidants and Redox Signaling · doi:10.1089/ars.2010.3283 · Cited by 181 · see citing works
Tüfekçi, K. U., Bayin, E. C., Genç, Ş., & Genç, K. (2011) · Parkinson s Disease · doi:10.4061/2011/314082 · Cited by 181 · see citing works
Zerumbone, a tropical ginger sesquiterpene, activates phase II drug metabolizing enzymes
Nakamura, Y., Yoshida, C., Murakami, A., Ohigashi, H., Osawa, T., & Uchida, K. (2004) · FEBS Letters · doi:10.1016/j.febslet.2004.07.042 · Cited by 181 · see citing works
Sussan, T. E., Jun, J. C., Thimmulappa, R. K., Bedja, D., Antero, M. F., Gabrielson, K. L., Polotsky, V. Y., & Biswal, S. S. (2008) · PLoS ONE · doi:10.1371/journal.pone.0003791 · Cited by 179 · see citing works
Eggler, A. L., Small, E., Hannink, M., & Mesecar, A. D. (2009) · Biochemical Journal · doi:10.1042/bj20090471 · Cited by 178 · see citing works
The Nrf2-Keap1-ARE Signaling Pathway: The Regulation and Dual Function of Nrf2 in Cancer
Zhang, D. D. (2010) · Antioxidants and Redox Signaling · doi:10.1089/ars.2010.3301 · Cited by 177 · see citing works
Scapagnini, G., Butterfield, D. A., Colombrita, C., Rukhsana Sultana, A., Pascale, A., & Calabrese, V. (2004) · Antioxidants and Redox Signaling · doi:10.1089/ars.2004.6.811 · Cited by 175 · see citing works
Narayanan, S., Kalayarasan, S., & Sudhandiran, G. (2008) · Pulmonary Pharmacology & Therapeutics · doi:10.1016/j.pupt.2008.12.010 · Cited by 174 · see citing works
Nishino, H., Nishino, A., Takayasu, J., Hasegawa, T., Iwashima, A., Hirabayashi, K., IWATA, S., & Shibata, S. (1988) · PubMed · Cited by 174 · see citing works
Kundu, J. K., & Surh, Y. (2010) · Pharmaceutical Research · doi:10.1007/s11095-010-0096-8 · Cited by 173 · see citing works
Electrophilic tuning of the chemoprotective natural product sulforaphane
Ahn, Y., Hwang, Y., Liu, H., Wang, X. J., Zhang, Y., Stephenson, K. K., Boronina, T. N., Cole, R. N., Dinkova‐Kostova, A. T., Talalay, P., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1004104107 · Cited by 170 · see citing works
Novel Chalcone Derivatives as Potent Nrf2 Activators in Mice and Human Lung Epithelial Cells
Kumar, V., Kumar, S., Hassan, M. A., Wu, H., Thimmulappa, R. K., Kumar, A., Sharma, S. K., Parmar, V. S., Biswal, S. S., & Malhotra, S. V. (2011) · Journal of Medicinal Chemistry · doi:10.1021/jm2002348 · Cited by 168 · see citing works
Targeting the Nrf2 pathway against cardiovascular disease
Li, J., Ichikawa, T., Janicki, J. S., & Cui, T. (2009) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728220903025762 · Cited by 168 · see citing works
Linnewiel‐Hermoni, K., Ernst, H., Caris, C., Ben-Dor, A., Kampf, A., Salman, H., Danilenko, M., Levy, J., & Sharoni, Y. (2009) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2009.06.008 · Cited by 166 · see citing works
Snow, E. T., Sýkora, P., Durham, T. R., & Klein, C. B. (2005) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2005.01.048 · Cited by 160 · see citing works
Shen, G., Xu, C., Hu, R., Jain, M. R., Nair, S., Lin, W., Yang, C. S., Chan, J. Y., & Kong, A.-N. T. (2005) · Pharmaceutical Research · doi:10.1007/s11095-005-7546-8 · Cited by 159 · see citing works
Posner, G. H., Cho, C., Green, J. V., Zhang, Y., & Talalay, P. (1994) · Journal of Medicinal Chemistry · doi:10.1021/jm00027a021 · Cited by 158 · see citing works
Mann, G. E., Bonacasa, B., Ishii, T., & Siow, R. C. (2009) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2008.12.012 · Cited by 158 · see citing works
Development of Cancer Chemopreventive Agents: Oltipraz as a Paradigm
Kensler, T. W., Groopman, J. D., Sutter, T. R., Curphey, T. J., & Roebuck, B. D. (1999) · Chemical Research in Toxicology · doi:10.1021/tx980185b · Cited by 158 · see citing works
The “Prochaska” Microtiter Plate Bioassay for Inducers of NQO1
Fahey, J. W., Dinkova‐Kostova, A. T., Stephenson, K. K., & Talalay, P. (2004) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/s0076-6879(04)82014-7 · Cited by 157 · see citing works
Activation of Nrf2 in Defense against Cadmium-Induced Oxidative Stress
He, X., Chen, M. G., & Ma, Q. (2008) · Chemical Research in Toxicology · doi:10.1021/tx800019a · Cited by 157 · see citing works
Reduction in Antioxidant Defenses may Contribute to Ochratoxin A Toxicity and Carcinogenicity
Cavin, C., Delatour, T., Marin‐Kuan, M., Holzhäuser, D., Higgins, L., Bezençon, C., Guignard, G., Junod, S., Richoz, J., Gremaud, E., et al. (2006) · Toxicological Sciences · doi:10.1093/toxsci/kfl169 · Cited by 154 · see citing works
He, X., & Ma, Q. (2009) · Molecular Pharmacology · doi:10.1124/mol.109.058453 · Cited by 153 · see citing works
Lin, C.-W., Wu, M., Liu, I. Y.-C., Jeng-Dian, S., & Yen, J.-H. (2010) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf904061x · Cited by 152 · see citing works
Regulation of Nrf2-dependent gene expression by 15-deoxy-Δ12,14-prostaglandin J2
Kansanen, E., Kivelä, A. M., & Levonen, A. (2009) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2009.06.030 · Cited by 150 · see citing works
Ebselen, a Seleno-organic Antioxidant, as an Electrophile
Sakurai, T., Kanayama, M., Shibata, T., Itoh, K., Kobayashi, A., Yamamoto, M. P., & Uchida, K. (2006) · Chemical Research in Toxicology · doi:10.1021/tx0601105 · Cited by 148 · see citing works
Holtzclaw, W. D., Dinkova‐Kostova, A. T., & Talalay, P. (2004) · Advances in Enzyme Regulation · doi:10.1016/j.advenzreg.2003.11.013 · Cited by 144 · see citing works
Electrophiles in Foods: The Current Status of Isothiocyanates and Their Chemical Biology
NAKAMURA, Y., & MIYOSHI, N. (2010) · Bioscience, Biotechnology, and Biochemistry · doi:10.1271/bbb.90731 · Cited by 143 · see citing works
Regulation of phase 2 enzyme induction by oltipraz and other dithiolethiones
Egner, P. A., Kensler, T. W., Prestera, T., Talalay, P., Libby, A. H., Joyner, H. H., & Curphey, T. J. (1994) · Carcinogenesis · doi:10.1093/carcin/15.2.177 · Cited by 142 · see citing works
Flagged first, then by citations
Research works printed but not linked: 2
- [264]Beamer LJ Lo SC Li XC Henzl MT Hannink M Structure of the Keap1: Nrf2 interface provides mechanistic insight into Nrf2 signaling Embo J 2006 25 15 3605 3617 16888629 PMC1538563
- [276]Gazaryan IG Smirnova NA Haskew-Layton RE Basso M Hushpulian DM Payappilly JB Speer RE Ahn YH Rakhman I Cole PA Pinto JT Ratan RR Development of Neh2-Luciferase Reporter and Its Application for High Throughput Screening and Real-Time Monitoring of Nrf2 Activators Chem Biol 2011 18 6 752 765 21700211 PMC3251032
Cited by
Sorted by citations
Chalcone: A Privileged Structure in Medicinal Chemistry
Zhuang, C., Zhang, W., Sheng, C., Zhang, W., Xing, C., & Miao, Z. (2017) · Chemical Reviews · doi:10.1021/acs.chemrev.7b00020 · Cited by 1,486 · see citing works
The emerging role of the Nrf2–Keap1 signaling pathway in cancerPreprint
Jaramillo, M. C., & Zhang, D. D. (2013) · Genes & Development · doi:10.1101/gad.225680.113 · Cited by 1,304 · see citing works
Glutathione metabolism in cancer progression and treatment resistance
Bansal, A., & Simon, M. C. (2018) · The Journal of Cell Biology · doi:10.1083/jcb.201804161 · Cited by 1,234 · see citing works
Lu, H., Zhou, Q., He, J., Jiang, Z., Peng, C., Tong, R., & Shi, J. (2020) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-020-00315-3 · Cited by 891 · see citing works
The Keap1–Nrf2–ARE Pathway As a Potential Preventive and Therapeutic Target: An Update
Lu, M., Ji, J., Jiang, Z., & You, Q. (2016) · Medicinal Research Reviews · doi:10.1002/med.21396 · Cited by 801 · see citing works
Tu, W., Wang, H., Li, S., Liu, Q., & Sha, H. (2018) · Aging and Disease · doi:10.14336/ad.2018.0513 · Cited by 712 · see citing works
Bhatti, J. S., Sehrawat, A., Mishra, J., Sidhu, I. S., Navik, U., Khullar, N., Kumar, S., Bhatti, G. K., & Reddy, P. (2022) · Free Radical Biology & Medicine · doi:10.1016/j.freeradbiomed.2022.03.019 · Cited by 649 · see citing works
Buendía, I., Michalska, P., Navarro, E., Gameiro‐Ros, I., Egea, J., & Leon, R. M. (2015) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2015.11.003 · Cited by 683 · see citing works
The Dual Roles of NRF2 in Cancer
Menegon, S., Columbano, A., & Giordano, S. (2016) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2016.05.002 · Cited by 633 · see citing works
Activators and Inhibitors of NRF2: A Review of Their Potential for Clinical Development
Robledinos-Antón, N., Fernández-Ginés, R., Manda, G., & Cuadrado, A. (2019) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2019/9372182 · Cited by 608 · see citing works
Diabetes, oxidative stress and therapeutic strategies
Rochette, L., Zeller, M., Cottin, Y., & Vergely, C. (2014) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2014.05.017 · Cited by 530 · see citing works
Formation and Biological Targets of Quinones: Cytotoxic versus Cytoprotective Effects
Bolton, J. L., & Dunlap, T. L. (2016) · Chemical Research in Toxicology · doi:10.1021/acs.chemrestox.6b00256 · Cited by 528 · see citing works
Nrf2/Keap1/ARE signaling: Towards specific regulation
Ulasov, A. V., Rosenkranz, A. A., Georgiev, G. P., & Sobolev, A. S. (2021) · Life Sciences · doi:10.1016/j.lfs.2021.120111 · Cited by 520 · see citing works
Repression of the Antioxidant NRF2 Pathway in Premature Aging
Kubben, N., Zhang, W., Wang, L., Voss, T. C., Yang, J., Qu, J., Liu, G.-H., & Misteli, T. (2016) · Cell · doi:10.1016/j.cell.2016.05.017 · Cited by 489 · see citing works
Mitochondria‐targeted antioxidants
Oyewole, A. O., & Birch‐Machin, M. A. (2015) · The FASEB Journal · doi:10.1096/fj.15-275404 · Cited by 467 · see citing works
Deshmukh, P. H., Unni, S., Krishnappa, G., & Padmanabhan, B. (2016) · Biophysical Reviews · doi:10.1007/s12551-016-0244-4 · Cited by 397 · see citing works
Chemistry and Biology of Resveratrol-Derived Natural Products
Keylor, M. H., Matsuura, B. S., & Stephenson, C. R. J. (2015) · Chemical Reviews · doi:10.1021/cr500689b · Cited by 372 · see citing works
Nanoformulations of curcumin: an emerging paradigm for improved remedial application
Gera, M., Sharma, N., Ghosh, M., Huynh, D. L., Lee, S., Min, T., Kwon, T., & Jeong, D. K. (2017) · Oncotarget · doi:10.18632/oncotarget.19164 · Cited by 356 · see citing works
Hrd1 suppresses Nrf2-mediated cellular protection during liver cirrhosisPreprint
Wu, T., Zhao, F. L., Gao, B., Tan, C., Yagishita, N., Nakajima, T., Wong, P. K., Chapman, E., Fang, D., & Zhang, D. D. (2014) · Genes & Development · doi:10.1101/gad.238246.114 · Cited by 355 · see citing works
Abed, D. A., Goldstein, M., Albanyan, H., Jin, H., & Hu, L. (2015) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2015.05.008 · Cited by 330 · see citing works
Muir, A., Danai, L. V., Gui, D. Y., Waingarten, C. Y., Lewis, C. A., & Vander Heiden, M. G. (2017) · eLife · doi:10.7554/elife.27713 · Cited by 311 · see citing works
Oncogenic KRAS Confers Chemoresistance by Upregulating NRF2
Tao, S., Wang, S., Moghaddam, S. J., Ooi, A., Chapman, E., Wong, P. K., & Zhang, D. D. (2014) · Cancer Research · doi:10.1158/0008-5472.can-14-1439 · Cited by 291 · see citing works
The Nrf2/HO‐1 Axis in Cancer Cell Growth and Chemoresistance
Furfaro, A. L., Traverso, N., Domenicotti, C., Piras, S., Moretta, L., Marinari, U. M., Pronzato, M. A., & Nitti, M. (2015) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2016/1958174 · Cited by 295 · see citing works
Khan, N. M., Haseeb, A., Ansari, M. Y., Devarapalli, P., Haynie, S., & Haqqi, T. M. (2017) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2017.02.041 · Cited by 289 · see citing works
Krajka‐Kuźniak, V., Paluszczak, J., & Baer‐Dubowska, W. (2016) · Pharmacological Reports · doi:10.1016/j.pharep.2016.12.011 · Cited by 288 · see citing works
Speisky, H., Shahidi, F., de Camargo, A. C., & Fuentes, J. (2022) · Antioxidants · doi:10.3390/antiox11010133 · Cited by 288 · see citing works
Mitochondrial Quality Control as a Therapeutic Target
Suliman, H. B., & Piantadosi, C. A. (2015) · Pharmacological Reviews · doi:10.1124/pr.115.011502 · Cited by 265 · see citing works
Structure of the BTB Domain of Keap1 and Its Interaction with the Triterpenoid Antagonist CDDO
Cleasby, A., Yon, J. R., Day, P. J., Richardson, C. J., Tickle, I. J., Williams, P. A., Callahan, J. F., Carr, R. A. E., Concha, N. O., Kerns, J. K., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0098896 · Cited by 263 · see citing works
Jiang, Z., Lu, M., Xu, L., Yang, T., Xi, M., Xu, X., Guo, X., Zhang, X., You, Q., & Sun, H.-P. (2014) · Journal of Medicinal Chemistry · doi:10.1021/jm5000529 · Cited by 263 · see citing works
TrxR1 as a Potent Regulator of the Nrf2-Keap1 Response System
Cebula, M., Schmidt, E. E., & Arnér, E. S. J. (2015) · Antioxidants and Redox Signaling · doi:10.1089/ars.2015.6378 · Cited by 251 · see citing works
Reactive oxygen species-mediated therapeutic response and resistance in glioblastoma
Singer, E. A., Judkins, J., Salomonis, N., Matlaf, L., Soteropoulos, P., McAllister, S. D., & Soroceanu, L. (2015) · Cell Death and Disease · doi:10.1038/cddis.2014.566 · Cited by 248 · see citing works
Kubo, E., Chhunchha, B., Singh, P., Sasaki, H., & Singh, D. P. (2017) · Scientific Reports · doi:10.1038/s41598-017-14520-8 · Cited by 231 · see citing works
Bulatov, E., & Ciulli, A. (2015) · Biochemical Journal · doi:10.1042/bj20141450 · Cited by 237 · see citing works
Recent Advances of Cell Membrane‐Coated Nanomaterials for Biomedical Applications
Liu, W., Zou, M., Qin, S., Cheng, Y., Ma, Y., Sun, Y., & Zhang, X. (2020) · Advanced Functional Materials · doi:10.1002/adfm.202003559 · Cited by 227 · see citing works
Birch-Machin, M. A., & Bowman, A. (2016) · British Journal of Dermatology · doi:10.1111/bjd.14906 · Cited by 225 · see citing works
Molecular and Chemical Regulation of the Keap1-Nrf2 Signaling Pathway
Keum, Y., & Choi, B. Y. (2014) · Molecules · doi:10.3390/molecules190710074 · Cited by 224 · see citing works
Resveratrol, an Nrf2 activator, ameliorates aging-related progressive renal injury
Kim, E. N., Lim, J. H., Kim, M. Y., Ban, T. H., Jang, I.-A., Yoon, H. E., Park, C. W., Chang, Y. S., & Choi, B. S. (2018) · Aging · doi:10.18632/aging.101361 · Cited by 222 · see citing works
Vitamin D cell signalling in health and disease
Berridge, M. J. (2015) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2015.01.008 · Cited by 214 · see citing works
Discovery of a small-molecule inhibitor and cellular probe of Keap1–Nrf2 protein–protein interaction
Hu, L., Magesh, S., Chen, L., Wang, L., Lewis, T. A., Chen, Y., Khodier, C., Inoyama, D., Beamer, L. J., Emge, T. J., et al. (2013) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2013.03.013 · Cited by 206 · see citing works
Activation of Nrf2 signaling by natural products-can it alleviate diabetes?
Matzinger, M., Fischhuber, K., & Heiß, E. H. (2017) · Biotechnology Advances · doi:10.1016/j.biotechadv.2017.12.015 · Cited by 205 · see citing works
Oncogenic functions of the transcription factor Nrf2
Gañán‐Gómez, I., Wei, Y., Yang, H., Boyano-Adánez, M. C., & Garcia‐Manero, G. (2013) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2013.06.041 · Cited by 200 · see citing works
Oxidative Stress in Alzheimer’s Disease: Are We Connecting the Dots?
Rosini, M., Simoni, E., Milelli, A., Minarini, A., & Melchiorre, C. (2013) · Journal of Medicinal Chemistry · doi:10.1021/jm400970m · Cited by 202 · see citing works
Sulforaphane Protects against Cardiovascular Disease via Nrf2 Activation
Bai, Y., Wang, X., Zhao, S., Ma, C., Cui, J., & Zheng, Y. (2015) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2015/407580 · Cited by 204 · see citing works
Novel target for treating Alzheimer’s Diseases: Crosstalk between the Nrf2 pathway and autophagy
Zhang, W., Feng, C., & Jiang, H. (2020) · Ageing Research Reviews · doi:10.1016/j.arr.2020.101207 · Cited by 200 · see citing works
Gao, A.-M., Ke, Z., Fang, S., Sun, G., & Chen, H. (2013) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2013.08.008 · Cited by 190 · see citing works
Ge, W., Zhao, K., Wang, X., Li, H., Yu, M., He, M., Xue, X., Zhu, Y., Zhang, C. L., Cheng, Y., et al. (2017) · Cancer Cell · doi:10.1016/j.ccell.2017.09.008 · Cited by 189 · see citing works
Binding Mode and Structure–Activity Relationships around Direct Inhibitors of the Nrf2–Keap1 Complex
Jnoff, E., Albrecht, C., Barker, J. J., Barker, O., Beaumont, E., Bromidge, S. M., Brookfield, F. A., Brooks, M., Bubert, C., Ceska, T., et al. (2014) · ChemMedChem · doi:10.1002/cmdc.201300525 · Cited by 180 · see citing works
Wang, K., Lv, Q., Miao, Y., Qiao, S., Dai, Y., & Wei, Z. (2018) · Biochemical Pharmacology · doi:10.1016/j.bcp.2018.07.039 · Cited by 179 · see citing works
Bradford, P. G. (2013) · BioFactors · doi:10.1002/biof.1074 · Cited by 178 · see citing works
An update of Nrf2 activators and inhibitors in cancer prevention/promotion
Pouremamali, F., Pouremamali, A., Dadashpour, M., Soozangar, N., & Jeddi, F. (2022) · Cell Communication and Signaling · doi:10.1186/s12964-022-00906-3 · Cited by 172 · see citing works
Keap Calm, and Carry on Covalently
Wilson, A. J., Kerns, J. K., Callahan, J. F., & Moody, C. J. (2013) · Journal of Medicinal Chemistry · doi:10.1021/jm400224q · Cited by 171 · see citing works
Anticancer Activity of Sulforaphane: The Epigenetic Mechanisms and the Nrf2 Signaling Pathway
Su, X., Jiang, X. M., Meng, L., Dong, X., Shen, Y., & Xin, Y. (2018) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2018/5438179 · Cited by 172 · see citing works
State-of-the-art strategies for targeting protein–protein interactions by small-molecule inhibitors
Sheng, C., Dong, G., Miao, Z., Zhang, W., & Wang, W. (2015) · Chemical Society Reviews · doi:10.1039/c5cs00252d · Cited by 165 · see citing works
Molecular mechanism of curcumin action in signaling pathways: Review of the latest research
Liczbiński, P., Michałowicz, J., & Bukowska, B. (2020) · Phytotherapy Research · doi:10.1002/ptr.6663 · Cited by 168 · see citing works
Yao, J., Zhang, B., Ge, C., Peng, S., & Fang, J. (2015) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf505075n · Cited by 166 · see citing works
Potential Applications of NRF2 Modulators in Cancer Therapy
Panieri, E., Djordjević, A. B., Telkoparan‐Akillilar, P., Cevik, D., Kouretas, D., Veskoukis, A. S., Skaperda, Z., Tsatsakis, A. M., Wallace, D., Süzen, S., et al. (2020) · Antioxidants · doi:10.3390/antiox9030193 · Cited by 165 · see citing works
Dual roles of NRF2 in tumor prevention and progression: Possible implications in cancer treatment
Moon, E. J., & Giaccia, A. (2015) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2014.11.009 · Cited by 160 · see citing works
Bai, X., Chen, Y., Hou, X., Huang, M., & Jin, J. (2016) · Drug Metabolism Reviews · doi:10.1080/03602532.2016.1197239 · Cited by 159 · see citing works
Phytochemicals as Anti-Inflammatory Agents in Animal Models of Prevalent Inflammatory Diseases
Shin, S. A., Joo, B. J., Lee, J. S., Ryu, G., Han, M., Kim, W. Y., Park, H. H., Lee, J. H., & Lee, C. S. (2020) · Molecules · doi:10.3390/molecules25245932 · Cited by 166 · see citing works
Luteolin inhibits the Nrf2 signaling pathway and tumor growth in vivo
Chian, S., Thapa, R., Chi, Z., Wang, X. J., & Tang, X. (2014) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2014.04.039 · Cited by 157 · see citing works
Zhuang, C., Narayanapillai, S. C., Zhang, W., Sham, Y. Y., & Xing, C. (2014) · Journal of Medicinal Chemistry · doi:10.1021/jm4017174 · Cited by 156 · see citing works
Ming, J., Ye, J., Zhang, Y., Xu, Q., Yang, X., Shao, X., Qiang, J., & Xu, P. (2019) · Fish & Shellfish Immunology · doi:10.1016/j.fsi.2019.12.074 · Cited by 155 · see citing works
Natural Products as Modulators of Nrf2 Signaling Pathway in Neuroprotection
Moratilla-Rivera, I., Sánchez, M., Valdés-González, J. A., & Gómez-Serranillos, M. P. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24043748 · Cited by 154 · see citing works
Role of Nrf2 in the pathogenesis of atherosclerosis
Mimura, J., & Itoh, K. (2015) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2015.06.019 · Cited by 150 · see citing works
Lu, M., Zhao, J., Liu, Y.-T., Liu, T., Tao, M., You, Q., & Jiang, Z. (2019) · Redox Biology · doi:10.1016/j.redox.2019.101266 · Cited by 148 · see citing works
Glutathione: Role in Oxidative/Nitrosative Stress, Antioxidant Defense, and Treatments
Raj, S. R., Bhattacharyya, C., Sarkar, A., Chakraborty, S., Sircar, E., Dutta, S., & Sengupta, R. (2021) · ChemistrySelect · doi:10.1002/slct.202100773 · Cited by 147 · see citing works
Matzinger, M., Fischhuber, K., Pölöske, D., Mechtler, K., & Heiß, E. H. (2019) · Redox Biology · doi:10.1016/j.redox.2019.101393 · Cited by 145 · see citing works
Targeting Nrf2 Signaling to Combat Chemoresistance
No, J. H., Kim, Y.-B., & Song, Y. S. (2014) · Journal of Cancer Prevention · doi:10.15430/jcp.2014.19.2.111 · Cited by 144 · see citing works
Target- and Mechanism-Based Therapeutics for Neurodegenerative Diseases: Strength in Numbers
Trippier, P. C., Labby, K. J., Hawker, D. D., Mataka, J., & Silverman, R. B. (2013) · Journal of Medicinal Chemistry · doi:10.1021/jm3015926 · Cited by 141 · see citing works
Recent applications of vinyl sulfone motif in drug design and discovery
Ahmadi, R., & Emami, S. (2022) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2022.114255 · Cited by 143 · see citing works
Controversy about pharmacological modulation of Nrf2 for cancer therapy
Milković, L., Žarković, N., & Saso, L. (2017) · Redox Biology · doi:10.1016/j.redox.2017.04.013 · Cited by 142 · see citing works
Transcription factor NRF2 as a promising therapeutic target for Alzheimer’s disease
Qu, Z., Sun, J., Zhang, W., Yu, J., & Zhuang, C. (2020) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2020.06.028 · Cited by 140 · see citing works
Therapeutic Targeting of the NRF2 Signaling Pathway in Cancer
Telkoparan‐Akillilar, P., Panieri, E., Cevik, D., Süzen, S., & Saso, L. (2021) · Molecules · doi:10.3390/molecules26051417 · Cited by 139 · see citing works
Delgado-Roche, L., Riera‐Romo, M., Mesta, F., Hernández-Matos, Y., Barrios, J. M., Martı́nez-Sánchez, G., & Al-Dalaien, S. M. (2017) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2017.06.017 · Cited by 137 · see citing works
Nrf2 activation through the inhibition of Keap1–Nrf2 protein–protein interaction
Lee, S., & Hu, L. (2020) · Medicinal Chemistry Research · doi:10.1007/s00044-020-02539-y · Cited by 136 · see citing works
Zhang, J., Li, M., Zhang, G., Tian, Y. T., Kong, F., Xiong, S., Zhao, S., Jia, D. T., Manyande, A., & Du, H. (2020) · Food Chemistry · doi:10.1016/j.foodchem.2020.127921 · Cited by 137 · see citing works
Hassan, S. S. U., Samanta, S., Dash, R., Karpiński, T. M. M., Habibi, E., Sadiq, A., Ahmadi, A., & BUNGAU, S. G. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.1015835 · Cited by 139 · see citing works
Peng, S., Zhang, B., Meng, X., Yao, J., & Fang, J. (2015) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5b00410 · Cited by 136 · see citing works
Turpaev, K. T. (2013) · Biochemistry (Moscow) · doi:10.1134/s0006297913020016 · Cited by 135 · see citing works
Toth, R. K., & Warfel, N. A. (2017) · Antioxidants · doi:10.3390/antiox6020027 · Cited by 130 · see citing works
Catechins: Protective mechanism of antioxidant stress in atherosclerosis
Sheng, Y., Sun, Y., Tang, Y., Yu, Y., Wang, J., Zheng, F., Li, Y., & Sun, Y. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1144878 · Cited by 134 · see citing works
Modulation of NRF2 signaling pathway by nuclear receptors: Implications for cancer
Namani, A., Li, Y., Wang, X. J., & Tang, X. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2014.05.003 · Cited by 126 · see citing works
Jiang, Z., Lu, M., & You, Q. (2016) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.6b00586 · Cited by 126 · see citing works
Bertrand, H. C., Schaap, M., Baird, L., Georgakopoulos, N., Fowkes, A., Thiollier, C., Kaatchi, H., Dinkova‐Kostova, A. T., & Wells, G. (2015) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5b00602 · Cited by 123 · see citing works
Edwards, M. R., Johnson, B., Mire, C. E., Xü, W., Shabman, R. S., Speller, L. N., Leung, D. W., Geisbert, T. W., Amarasinghe, G. K., & Basler, C. F. (2014) · Cell Reports · doi:10.1016/j.celrep.2014.01.043 · Cited by 119 · see citing works
Shen, Q., Ji, F., Guo, H., Su, X., Zhu, B., Yao, X., Wang, Y., Cao, A., Wang, H., & Wang, L. (2023) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2023.03.022 · Cited by 119 · see citing works
Vartanian, S., Ma, T. P., Lee, J., Haverty, P. M., Kirkpatrick, D. S., Yu, K., & Stokoe, D. (2015) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m115.055509 · Cited by 118 · see citing works
Pharmacological Applications of Antioxidants: Lights and Shadows
Saso, L., & Firuzi, O. (2014) · Current Drug Targets · doi:10.2174/1389450115666141024113925 · Cited by 118 · see citing works
Arora, R., Sawney, S., Saini, V., Steffi, C., Tiwari, M., & Saluja, D. (2016) · Molecular Cancer · doi:10.1186/s12943-016-0550-2 · Cited by 117 · see citing works
Wang, S., Xu, Y., Weng, Y., Fan, X., Bai, Y., Zheng, X., Lou, L.-J., & Zhang, F. (2018) · Food and Chemical Toxicology · doi:10.1016/j.fct.2018.02.041 · Cited by 116 · see citing works
Chemopreventive activity of sulforaphane
Jiang, X. M., Liu, Y., Ma, L., Ji, R., Qu, Y., Xin, Y., & Lv, G. (2018) · Drug Design Development and Therapy · doi:10.2147/dddt.s100534 · Cited by 115 · see citing works
Koeberle, S. C., Kipp, A. P., Stuppner, H., & Koeberle, A. (2023) · Medicinal Research Reviews · doi:10.1002/med.21933 · Cited by 115 · see citing works
Chian, S., Li, Y., Wang, X. J., & Tang, X. (2014) · Asian Pacific Journal of Cancer Prevention · doi:10.7314/apjcp.2014.15.6.2911 · Cited by 114 · see citing works
Dual protection of hydroxytyrosol, an olive oil polyphenol, against oxidative damage in PC12 cells
Peng, S., Zhang, B., Yao, J., Duan, D., & Fang, J. (2015) · Food & Function · doi:10.1039/c5fo00097a · Cited by 112 · see citing works
Counteracting role of nuclear factor erythroid 2-related factor 2 pathway in Alzheimer's disease
Sharma, V., Kaur, A., & Singh, T. G. (2020) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2020.110373 · Cited by 114 · see citing works
Pallesen, J. S., Tran, K. T., & Bach, A. (2018) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.8b00358 · Cited by 111 · see citing works
The clinical potential of influencing Nrf2 signaling in degenerative and immunological disorders
Hybertson, B. M., Gao, B., & Doan, A. (2014) · Clinical Pharmacology Advances and Applications · doi:10.2147/cpaa.s35078 · Cited by 110 · see citing works
Probing the structural requirements of non-electrophilic naphthalene-based Nrf2 activators
Jain, A. D., Potteti, H. R., Richardson, B. G., Kingsley, L. J., Luciano, J. P., Ryuzoji, A. F., Lee, H., Krunić, A., Mesecar, A. D., Reddy, S. P., et al. (2015) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2015.08.049 · Cited by 109 · see citing works
Protective Effects of Melatonin on the Skin: Future Perspectives
Rusanova, I., Martínez-Ruiz, L., Florido, J., Rodríguez-Santana, C., Guerra‐Librero, A., Acuña-Castroviejo, D., & Escames, G. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20194948 · Cited by 109 · see citing works
Kang, Y., Song, Y., Luo, Y., Song, J. T., Li, C., Yang, S., Guo, J., Yu, J. M., & Zhang, X. (2022) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2022.08.037 · Cited by 110 · see citing works
- Authors
- Magesh, S., Chen, Y., & Hu, L.
- Affiliations
- Rutgers, The State University of New Jersey (US)
- Corresponding author
- Hu, Longqin
- ORCID
- Venue
- Medicinal Research Reviews
- Publisher
- Wiley
- Published
- 2012-05
- Volume
- 32
- Issue
- 4
- Pages
- 687-726
- ISSN
- 0198-6325 (ISSN-L)
- 1098-1128
- PMC
- PMC3393814
- OpenAlex
- W1767659454
- Cited by
- 760
- References
- 275
- Citations by year
- 2026: 30 · 2025: 39 · 2024: 52 · 2023: 61 · 2022: 69 · 2021: 58 · 2020: 85 · 2019: 81 · 2018: 54 · 2017: 63 · 2016: 41 · 2015: 56 · 2014: 42 · 2013: 28 · 2012: 1
- FWCI
- 3.79
- Type
- journal article
- Language
- en
- Open access
- green
- europepmc.org
- Locations
- Medicinal Research Reviews (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institutes of Health (CA133791, CA125868, MH093197)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics, phytochemicals, and oxidative stress
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Redox biology and oxidative stress
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Toxicology › Bioactive Compounds and Antitumor Agents
- Keywords
- Nrf2/Keap1 pathway, Nrf2, Keap1, antioxidant response element, small molecule modulators, Nrf2 inducers, Nrf2 inhibitors, oxidative stress, xenobiotic detoxification, antioxidant defense, cancer chemotherapy resistance, peptide inhibitors, Keap1-Nrf2 interaction
- MeSH terms
- Animals, Anti-Inflammatory Agents, Antineoplastic Agents, Antioxidants, Humans, Hypoglycemic Agents, Signal Transduction, Oxidative Stress, Neuroprotective Agents, Response Elements, Intracellular Signaling Peptides and Proteins, NF-E2-Related Factor 2
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review